NCBI PubMed Central
open access
A serum-clinical composite model for prostate cancer diagnosis: multicenter validation and CRISPR/Cas13a-based detection.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Treatment Approaches and Biomarkers PRevalence In de Novo MEtastatic Hormone-sensitive Prostate Cancer in Russian Federation#856724
- Diagnosis of Prostate Cancer: A Comparative Evaluation of Biological Techniques.#315526
- Active Surveillance in Prostate Cancer : Current and Potentially Emerging Biomarkers for Patient Selection Criteria#292984
- Update and Biodistribution of [F-18]FMDHT pET/CT in Normal Healthy Volunteers and Patients With Metastatic Prostate Cancer - A First in Human Subject Study With [F-18] FMDHT#1088103
- Biosensor Technologies for Prostate Cancer : Early Detection and Precision Diagnosis / edited by Shriyansh Srivastava, Molakpogu Ravindra Babu, Shashank Shekhar#1153960
Record · ID 436938
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive